Sernova Biotherapeutics Inc (TSX:SVA)
Canada · Delayed Price · Currency is CAD 0.1400
0.00 (0.00%)
Mar 3, 2026, 3:45 PM EST
Sernova Biotherapeutics Market Cap
Sernova Biotherapeutics has a market cap or net worth of CAD 47.47 million as of March 4, 2026. Its market cap has decreased by -27.74% in one year.
Market Cap
47.47M
Enterprise Value
51.98M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
Market Cap Chart
Since June 29, 2000, Sernova Biotherapeutics's market cap has increased from 17.04M to 47.47M, an increase of 178.66%. That is a compound annual growth rate of 4.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 47.47M | 8.46% |
| Dec 31, 2025 | 43.77M | -40.78% |
| Dec 31, 2024 | 73.91M | -67.09% |
| Dec 29, 2023 | 224.60M | -3.01% |
| Dec 30, 2022 | 231.57M | -51.28% |
| Dec 31, 2021 | 475.26M | 238.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ME Therapeutics Holdings | 75.12M |
| Medicenna Therapeutics | 72.58M |
| Sharp Therapeutics | 67.67M |
| NurExone Biologic | 57.17M |
| MedMira | 48.82M |
| BriaCell Therapeutics | 40.17M |
| Devonian Health Group | 38.03M |
| Resverlogix | 37.89M |